Answers are grounded in this paper and cite their sources.
In the Americas, approximately 20 million people suffer from the chronic phases of Chagas' disease, of which chagasic cardiomyopathy is the most important clinical feature. The elimination of Trypanosoma cruzi is a pivotal step in arresting the evolution of the disease. Unfortunately, currently available chemotherapy is mostly ineffective due to its limited efficacy and toxic side effects. The following case highlights the efficacy of new diagnostic and follow-up methods in the evaluation of novel trypanocidal compounds such as amiodarone and itraconazole.
No takes yet. Share an insight, caveat, or question.
Paniz‐Mondolfi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: